Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism.
暂无分享,去创建一个
[1] G. Remuzzi,et al. Angiotensin-converting enzyme inhibitor therapy for non-diabetic progressive renal disease , 1997, Current opinion in nephrology and hypertension.
[2] G. Remuzzi,et al. Understanding the nature of renal disease progression. , 1997, Kidney international.
[3] A. Davidoff,et al. Antihypertensive drug treatment in chronic renal allograft rejection in the rat. Effect on structure and function. , 1996, Transplantation.
[4] B. Brenner,et al. Antigen-independent determinants of late renal allograft outcome: the role of renal mass. , 1996, Current opinion in nephrology and hypertension.
[5] A. Matsumori,et al. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. , 1996, Circulation.
[6] G. Remuzzi,et al. The renoprotective action of angiotensin-converting enzyme inhibitors in diabetes. , 1996, Experimental nephrology.
[7] H. Benediktsson,et al. Post-transplant hypertension and chronic renal allograft failure. , 1995, Kidney international. Supplement.
[8] H. Neumayer,et al. A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function. , 1995, Clinical nephrology.
[9] T. Hostetter,et al. Physiological and structural responses to chronic experimental renal allograft injury. , 1994, The American journal of physiology.
[10] Harald,et al. Nephron supply is a major determinant of long-term renal allograft outcome in rats. , 1994, The Journal of clinical investigation.
[11] J. Curtis,et al. Hypertension following kidney transplantation. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] G. Gores,et al. Systemic and Renal Effects of Nifedipine in Cyclosporine‐Associated Hypertension , 1994, Hypertension.
[13] C. Mavroudis,et al. Captopril Reduces Graft Coronary Artery Disease in a Rat Heterotopic Transplant Model , 1993, Circulation.
[14] N. Perico,et al. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. , 1993, Journal of the American Society of Nephrology : JASN.
[15] A. Davidoff,et al. GLOMERULAR CAPILLARY PRESSURES IN LONG‐SURVIVING RAT RENAL ALLOGRAFTS , 1993, Transplantation.
[16] P. Charpiot,et al. Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs. , 1993, The American journal of cardiology.
[17] M. Epstein. Calcium antagonists and the kidney: future therapeutic perspectives. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] B. Brenner,et al. Nephron underdosing: a programmed cause of chronic renal allograft failure. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] H. Benediktsson,et al. Chronic transplant rejection: Magnitude of the problem and pathogenetic mechanisms , 1993 .
[20] N. Perico,et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. , 1993, Kidney international.
[21] L. Ruilope,et al. Calcium antagonists and renal protection , 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[22] G. Wolf,et al. Angiotensin II as a renal growth factor. , 1993, Journal of the American Society of Nephrology : JASN.
[23] G. Ding,et al. PROGRESSIVE ALBUMINURIA AND GLOMERULOSCLEROSIS IN A RAT MODEL OF CHRONIC RENAL ALLOGRAFT REJECTION , 1992, Transplantation.
[24] T. Meyer,et al. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. , 1992, The Journal of clinical investigation.
[25] B. Brenner,et al. In renal transplantation, one size may not fit all. , 1992, Journal of the American Society of Nephrology : JASN.
[26] C. Alpers,et al. Renal injury from angiotensin II-mediated hypertension. , 1992, Hypertension.
[27] B. Brenner,et al. Nifedipine versus fosinopril in uninephrectomized diabetic rats. , 1992, Kidney international.
[28] A. Sagalowsky,et al. IMPROVED OUTCOME OF CADAVERIC RENAL TRANSPLANTATION DUE TO CALCIUM CHANNEL BLOCKERS , 1991, Transplantation.
[29] D. Adams,et al. Chronic rejection--an undefined conundrum. , 1991, Transplantation.
[30] L. Dworkin,et al. Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. , 1991, Kidney international.
[31] D. O'donoghue,et al. A prospective study of prophylactic ATG versus cyclosporine in regrafted and highly sensitized renal allograft recipients. , 1990, Transplantation.
[32] L. Dworkin,et al. Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension. , 1990, The American journal of physiology.
[33] J. Madri,et al. Influence of the angiotensin system on endothelial and smooth muscle cell migration. , 1990, The American journal of pathology.
[34] A. Chobanian,et al. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. , 1990, Hypertension.
[35] G. Remuzzi,et al. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. , 1990, The Journal of clinical investigation.
[36] T. Meyer,et al. Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy , 1990, Diabetes.
[37] E. Podjarny,et al. Captopril, but not diltiazem, favorably affects the course of early chronic renal disease in rats. , 1990, Nephron.
[38] M. Mihatsch,et al. Long-term enalapril and verapamil in rats with reduced renal mass. , 1989, Kidney international.
[39] B. Brenner,et al. Short and long term effects of antihypertensive therapy in the diabetic rat. , 1989, Kidney international.
[40] D. Harris,et al. Verapamil protects against progression of experimental chronic renal failure. , 1987, Kidney international.
[41] B. Brenner,et al. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. , 1986, The Journal of clinical investigation.
[42] B. Brenner,et al. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. , 1986, The Journal of clinical investigation.
[43] C. Johnston,et al. PRESERVATION OF RENAL FUNCTION IN THE RAT REMNANT KIDNEY MODEL OF CHRONIC RENAL FAILURE BY BLOOD PRESSURE REDUCTION , 1986, Clinical and experimental pharmacology & physiology.
[44] B. Brenner,et al. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. , 1985, The Journal of clinical investigation.
[45] J. Fleiss,et al. Some Statistical Methods Useful in Circulation Research , 1980, Circulation research.
[46] M. Pfeffer,et al. Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. , 1971, The Journal of laboratory and clinical medicine.
[47] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[48] H. W. Smith,et al. THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN. , 1945, The Journal of clinical investigation.